Our study demonstrates that during co-culture, human bone tissues preferentially sustain ER+ breast cancer cells, and that aromatase inhibitors effectively target the estrogen axis in bone tissues to specifically modulate the behavior of ER+ breast cancer cells. This evidence concerns the gene ESR1 and breast carcinoma.